Hemofília: vizsgálatok itt: Tajvan
10 trials · From ClinicalTrials.gov, checked 2026. november 11.. Ask the study team whether a trial fits you.
- 4. fázisTaking peopleEfanesoctocog Alfa Prophylaxis in Patients With Hemophilia A With Synovial Hypertrophy
- Where
- Kaohsiung City, Taichung, Taipei
- Életkor
- 12 év and over
- People
- 35 worldwide
- Run by
- Sanofi
See details and how to joinNCT06941870 - 3. fázisTaking peopleA Clinical Study to Evaluate the Effects of NXT007 Compared to Emicizumab Prophylaxis in People With Hemophilia A
- Where
- Taipei
- Életkor
- 12 év and over
- People
- 360 worldwide
- Run by
- Hoffmann-La Roche
See details and how to joinNCT07416604 · EU 2025-522435-33-00 - 3. fázisTaking peopleA Study to Investigate the Efficacy and Safety of Fitusiran Prophylaxis in Male Participants Aged 1 to Less Than 12 Years With Hemophilia A or B
- Where
- Taichung, Taipei City
- Életkor
- 1 év to 11 év
- People
- 85 worldwide
- Run by
- Sanofi
See details and how to joinNCT07285460 · EU 2025-521858-42-00 - 3. fázisTaking peopleOpen-Label Extension Study of Marstacimab in Hemophilia Participants With or Without Inhibitors
- Where
- Changhua, Taichung, Taipei
- Életkor
- 1 év to 74 év
- People
- 245 worldwide
- Run by
- Pfizer
See details and how to joinNCT05145127 · EU 2022-500470-33-00 - 3. fázisTaking peopleA Clinical Study to Evaluate the Effects of NXT007 Compared to Factor VIII Prophylaxis in Participants With Hemophilia A
- Where
- Taichung, Taipei
- Életkor
- 12 év and over
- People
- 138 worldwide
- Run by
- Hoffmann-La Roche
See details and how to joinNCT07416526 · EU 2025-522434-32-00 - 3. fázisTaking peopleA Clinical Trial of Study Medicine (Marstacimab) in Pediatric Patients With Hemophilia A or Hemophilia B
- Where
- Taichung, Taipei
- Életkor
- 1 év to 17 év
- People
- 100 worldwide
- Run by
- Pfizer
See details and how to joinNCT05611801 · EU 2022-500495-65-00 - 3. fázisTaking peopleSafety and Effectiveness of Giroctocogene Fitelparvovec or Fidanacogene Elaparvovec in Patients With Hemophilia A or B Respectively
- Where
- Changhua, Kaohsiung City, Taichung, Taipei
- Életkor
- 18 év and over
- People
- 173 worldwide
- Run by
- Pfizer
See details and how to joinNCT05568719 - 4. fázisTaking peopleA Study to Test a Medicine (Fitusiran) for Preventing Bleeds in People With Severe Hemophilia Who Previously Received Preventive Treatment With Emicizumab
- Where
- Taipei
- Életkor
- 12 év and over
- People
- 20 worldwide
- Run by
- Sanofi
See details and how to joinNCT06145373 · EU 2022-502414-84-00 - 3. fázisTaking peopleEfficacy and Safety of CSL222 (Etranacogene Dezaparvovec) Gene Therapy in Adults With Hemophilia B With Pretreatment Adeno-associated Virus Serotype 5 (AAV5) Neutralizing Antibodies (Nabs)
- Where
- Chang-hua, Kaohsiung City, Taichung, Taipei
- Életkor
- 18 év and over
- People
- 35 worldwide
- Run by
- CSL Behring
See details and how to joinNCT06003387 · EU 2023-509590-23-00 - No phaseTaking peopleA Study on the Bone-health Effectiveness of Applying Recombinant Factor VIII Fc (rFVIIIFc) to Patients With Hemophilia A (Prototype A)
- Where
- Taipei
- People
- 45
- Run by
- Tri-Service General Hospital (TSGH)
See details and how to joinNCT05981274